Kadoglou, Nikolaos P E <br/><br/>
Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy.  [electronic resource] 

 -  Clinical drug investigation  Mar 2014 
 - 165-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1918 
<br/><br/><label>Standard No.: </label>10.1007/s40261-013-0157-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Coronary Artery Disease--blood<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Male<br/>Middle Aged<br/>Osteopontin--blood<br/>Osteoprotegerin--blood<br/>Prospective Studies<br/>Treatment Outcome<br/>alpha-2-HS-Glycoprotein--metabolism